Testimonials
"I very much enjoyed the presentations from financial institutions and others addressing global market trends, as I don't typically hear that perspective in other conferences."
- Vanessa Ott, Promega
"Fantastic opportunity to learn, connect the dots, meet people and have both science and business discussions."
- Gregory Frank, GE HealthCare
"I enjoyed the blend of science, business and representation from pharma, biotech, and platforms"
-Matt Silver, Takeda
"It was an exhilarating event, uniting experts from the biotech industry, finance sector, and pharmaceutical companies. All united by the passion of advancing Immuno-oncology-based therapies and curiosity for the future directions of the IO field, making it a notable occasion for collaboration and knowledge exchange."
- Biond Biologics
"IO360 was such a great opportunity to see good friends, learn of new and merging data, and get fresh perspectives from a full spectrum of stakeholders that give it the name."
- Dr James Gulley, National Cancer Institute
"Congratulations again on the excellent program for the Immuno-Oncology 360° meeting. It was truly well coordinated and the topics were fantastic!"
- Dr Gilson Baia, Champions Oncology
"IO360° was one of the best immuno-oncology meetings I’ve been to. Kudos! Great speakers and great dialogue!"
- Jim Mansfield, PerkinElmer
"Thank you again for the amazing invitation, it was truly my pleasure to be able to participate in the excellent event you organized."
- Dr Christine Ward, BMS
"Really good, well-rounded and novel content. Congratulations on filling the house beyond capacity and for securing such an impressive speaking faculty."
- Eileen Daniels, Nektar Therapeutics
"The conference was informative on many fronts; not just scientific progress but also with Big Pharma vs small bio perspective and the investment community. I really enjoyed the Women's Luncheon to hear different perspectives from women leaders in our field."
- Laura Agensky, CUE Biopharma
"The breadth and depth of this IO dedicated meeting is just unmatched, and it becomes better year after year. Kudos."
-Dr Samuel Zhang, Gracell Biotechnologies
"Excellent speakers, diverse topics and good perspectives."
- Scott Turner, Pliant Therapeutics
"Your team did a wonderful job in putting together an interesting and relevant program."
- Lew Bender, Intensity Therapeutics
"I really enjoyed it and connecting with some really interesting and inspiring people with whom I'm sure this is just the beginning of long standing interactions."
- Jacqueline Karmel, Roche
"Nice mixture of large pharma and smaller drug discovery companies."
- Spencer Eggen, Bruker
2025 Sponsors
